Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish Heart Failure Registry

被引：0
|
作者：
Becher, P. M. Peter Moritz [1 ]
Savarese, G. S. [2 ]
Benson, L. [2 ]
Dahlstrom, U. [3 ,4 ]
Bhatt, D. L. [5 ]
Pitt, B. [6 ]
Lund, L. H. [2 ]
机构：
[1] Univ Heart & Vasc Ctr Hamburg, Hamburg, Germany
[2] Karolinska Univ Hosp, Cardiol, Stockholm, Sweden
[3] Linkoping Univ, Dept Cardiol, Linkoping, Sweden
[4] Linkoping Univ, Dept Hlth Med & Caring Sci, Linkoping, Sweden
[5] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA USA
[6] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：194 / 195
页数：2
相关论文
共 50 条
  • [21] HEART FAILURE HOSPITALIZATIONS AND URGENT HEART FAILURE VISITS FOR PATIENTS WITH HEART FAILURE IN A REAL-WORLD POPULATION IN THE US
    Lam, Carolyn
    Wood, Robert
    Bueno, Hector
    Vaduganathan, Muthiah
    Luporini, Gabriela
    Chin, Alex
    Siddiqui, Afrah
    Sorstadius, Elisabeth
    Thomas, Joseph
    Qin, Lei
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 890 - 890
  • [22] Real-world use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry
    Stolfo, Davide
    Lund, Lars H.
    Benson, Lina
    Lindberg, Felix
    Ferrannini, Giulia
    Dahlstrom, Ulf
    Sinagra, Gianfranco
    Rosano, Giuseppe M. C.
    Savarese, Gianluigi
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (09) : 1648 - 1658
  • [23] Diabetes and treatment of chronic heart failure in a large real-world heart failure population
    Radhoe, Sumant P.
    Veenis, Jesse F.
    Linssen, Gerard C. M.
    van der Lee, Chris
    Eurlings, Luc W. M.
    Kragten, Hans
    Al-Windy, Nadea Y. Y.
    van der Spank, Aukje
    Koudstaal, Stefan
    Brunner-La Rocca, Hans-Peter
    Brugts, Jasper J.
    [J]. ESC HEART FAILURE, 2022, 9 (01): : 353 - 362
  • [24] The Effect of the Dual SGLT1 and 2 Inhibitor Sotagliflozin on Cardiovascular Mortality and Hospital Readmission Rates for Heart Failure at 30 and 90 Days Post Discharge in Patients With Type 2 Diabetes Hospitalized for Worsening Heart Failure in the SOLOIST-WHF Trial
    Pitt, Bertram
    Bhatt, Deepak L.
    Szarek, Michael
    Sun, Franklin
    Davies, Michael J.
    Steg, Philippe G.
    [J]. CIRCULATION, 2022, 146
  • [25] Use of mineralocorticoid receptor antagonists in a real-world population with heart failure and reduced ejection fraction: an analysis of 24,529 patients from the swedish heart failure registry
    Savarese, G.
    Carrero, J. J.
    Pitt, B.
    Anker, S.
    Dahlstrom, U.
    Lund, L. H.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 344 - 344
  • [26] Empagliflozin Targeting the Real-World Heart Failure Population
    Rocha, Bruno M. L.
    Gomes, Rita V.
    Cunha, Goncalo J. L.
    Mendes, Goncalo
    Morais, Rui
    Campos, L.
    Araujo, Ines
    Fonseca, Candida
    [J]. JOURNAL OF CARDIAC FAILURE, 2019, 25 (03) : 218 - 219
  • [27] Empagliflozin targeting the real-world heart failure population
    Gomes, R.
    Rocha, B.
    Cunha, G.
    Silva, B.
    Morais, R.
    Araujo, I.
    Fonseca, C.
    Campos, L.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 988 - 988
  • [28] Empagliflozin in a real-world chronic heart failure population
    Rocha, M. L.
    Cunha, G. C.
    Gomes, R. M.
    Morais, R.
    Campos, L.
    Araujo, I.
    Fonseca, M. C.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 3068 - 3068
  • [29] Diabetes and contemporary treatment of chronic heart failure in a large real-world heart failure population
    Radhoe, S. P.
    Veenis, J. F.
    Linssen, G. C. M.
    Van der Lee, C.
    Eurlings, L. W. M.
    Kragten, H.
    Al-Windy, N. Y. Y.
    Van der Spank, A.
    Koudstaal, S.
    Brunner-La Rocca, H. P.
    Brugts, J. J.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 130 - 131
  • [30] Real-world use of sodium-glucose co-transporter 2 inhibitors in patients with heart failure and reduced ejection fraction: data from the Swedish heart failure registry
    Stolfo, D. Davide
    Lund, L.
    Benson, L.
    Lindberg, F.
    Dahlstrom, U.
    Sinagra, G.
    Rosano, G.
    Savarese, G.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 192 - 192
12345